tricular dysfunction, and tricuspid regurgitation, indicative of increased right ventricular stroke volume. A pulmonary-tosystemic flow ratio of 2:1, due to an ostium secundum type-atrial septal defect, could be accurately diagnosed by Doppler echocardiography. Symptoms disappeared spontanously within a few minutes after hospital admission without therapy.
Laboratory examination revealed elevated serum concentrations of cardiac troponin I (2.2 ng/mL; normal Ͻ 1.6 ng mL) and myocardial band (MB) isoenzyme of creatine kinase (13 U/L; normal Ͻ 5 U/L). MB isoenzyme of creatine kinase peaked (17 U/L) 4 h after hospital admission, and the level of troponin I raised to a peak concentration of 6.4 ng/mL. Other laboratory findings, including inflammatory markers and coagulation tests, were within normal ranges. Coronary angiography showed normal epicardial coronary vessels with no signs of atherosclerotic lesions, and a cineangiogram revealed no wall motion abnormalities.
For several reasons, we do not believe that ischemia caused the elevation of cardiac enzymes. First, a normal coronary angiogram finding does not definitely rule out previous coronary artery occlusion, but it makes myocardial ischemia or myocardial infarction unlikely, particularly in the absence of known risk factors for atherosclerosis. 4, 5 Second, neither echocardiography nor cineangiography revealed any wall-motion abnormalities indicative of segmental myocardial damage. Third, elevated concentrations of cardiac troponin have been reported in patients with dilated cardiomyopathy, secondary cardiomyopathies, and acute right ventricular dysfunction. 1, 3 To our knowledge, this is the first report in which heavyresistance exercise induced a raise of levels of serum cardiac troponin and MB isoenzyme of creatine kinase in a patient with preexisting dilatation and dysfunction of the right ventricle due to a ostium secundum type-atrial septal defect with left-to-right shunt.
The management of atrial septal defects in older patients is debated persistently, and clinical trials 6, 7 have demonstrated conflicting data. We do not have absolute proof to guide our decisions; therefore, we must rely on our experience as well as on the available evidence in deciding how to treat these patients. 8 Further studies are needed to determine whether the management of these patients should be guided by clinical signs or by biochemical markers, like troponins. 
Effects of Cardiac Glycosides on Atrial Fibrillation
To the Editor:
The experimental investigation of Friedman et al (October 2000) 1 demonstrated that acetylstrophanthidin (AS) exerts a favorable effect on atrial fibrillation (AF)-induced atrial stunning, action that was not related to its effects on the duration of AF. In this study, the effect of cardiac glycosides on the duration of AF deserves further analysis.
Following atrial stimulation, the authors observed that "although the baseline duration . . . of AF in control dogs was the same as that found in . . . dogs before the administration of the glycoside (102 Ϯ 70 s vs 106 Ϯ 72 s), AF duration in the control dogs at a time comparable to that at which the glycoside had been administered was sharply lower (106 Ϯ 72 s vs 7 Ϯ 3 s; p ϭ 0.12 . . . ). Thus, the lack of a difference in AF duration following AS might actually indicate an enhancement of the arrhythmia by the glycoside." 1 Friedman et al 1 further stated that "randomized controlled studies . . . have demonstrated little benefit of these drugs for alleviation AF. When compared to controls, neither IV nor oral cardiac glycosides have been found to increase the number of cardioversions or to shorten the time it takes for the cessation of AF," and also "the administration of IV or oral cardiac glycosides does not appear to be effective in converting or shortening episodes of AF," findings that were considered "consistent with the effects of AS on experimental AF observed in this study." 1 Digoxin had been considered to have no efficacy for conversion of AF to sinus rhythm. 2, 3 However, trials have shown the advantage of digoxin over placebo for conversion to sinus rhythm in patients with shorter AF duration ( Ͻ 72 h). 4 -6 As the AF induced in the study had a very short duration, 1 their experimental model probably was very susceptible to the action of digoxin in the conversion of AF. Furthermore, the reported reduction in AF duration, in comparison with the dogs that received AS, did not reach statistical significance.
I do believe that the favorable effect of cardiac glycosides on AF-induced atrial stunning might be important in clinical practice and should be established in clinical investigations. However, the role of the cardiac glycosides in the duration of AF deserves further investigation to clarify the differences between clinical and experimental studies.
Henrique Horta Veloso, MD Santa Casa de Misericó rdia
Belo Horizonte, Brazil 
A Retrospective Study of Metastatic Lung Cancer Compression of the Cauda Equina
Spinal cord compression by metastatic tumor is more commonly encountered than is compression of the cauda equina. 1 Lung cancer reportedly metastasizes more often to the thoracic segments of the spine than to other parts of the vertebral column. 2, 3 The paucity of data concerning patients' outcomes in cases of cauda equina compression by metastatic lung cancer (CEC-MLC) and the pervading interest in outcomes research prompted this retrospective study of patients.
From 1984 to 1997, 2,285 new cases of documented lung cancer were evaluated at two university-affiliated hospitals. From a review of the radiation oncology patient records, 16 cases (0.7%) of CEC-MLC were identified.
The diagnosis of compression of the cauda equina was based on clinical examination and radioimaging findings. Myelography was used more frequently than MRI to demonstrate the metastatic lesion and the thecal/neural sac compression.
CEC-MLC affected men more than women (Table 1) . Back pain and impaired muscle strength of the lower limbs were the predominant manifestations. The average duration of symptoms and signs of cauda equina compression was 89 days (range, 1 to 270 days). The most common histologic type of bronchogenic carcinoma was non-small cell cancer. The upper lobe of the lungs was affected the most. Ten patients had known metastatic disease elsewhere in the body. The lumbar segments of the cauda equina were mainly affected, rather than the sacral portions.
Treatment consisted of localized radiotherapy using a megavoltage photon beam from a 6-mV linear accelerator. The applied total dose was usually 30 Gy in 10 fractions, administered daily for 5 consecutive days. Corticosteroid medication, administered in a tapering fashion, was initiated as soon as the diagnosis of CEC-MLC was established. The achievement of palliation is shown in Table 2 . The overall average survival was 2 months (range 1 to 13 months). The poor prognosis observed in the present study is in accord with that noted by other investigators. 4 Tatsui and colleagues, 4 in evaluating survival of patients after the detection of spinal metastases, found that survival was shorter in individuals with lung cancer compared with survival of patients with breast cancer (3.6 Ϯ 6.1 months vs 29.4 Ϯ 33.5 months, respectively). 
